Session » 5T113 Abstracts: Late-Breaking Abstract Session

Date: Tuesday, October 23, 2018

Time: 4:00PM-6:00PM

Meeting: 2018 ACR/ARHP Annual Meeting

4:00PM-6:00PM: Abstract Number: L18

A Randomized Controlled 24-Week Trial Evaluating the Safety and Efficacy of Blinded Tapering Versus Continuation of Long-Term Prednisone (5 mg/day) in Patients with Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission on Tocilizumab

4:00PM-6:00PM: Abstract Number: L17

Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Psa: Results from a 48-Week Phase 2b, Randomized, Double‑Blind, Placebo-Controlled, Dose-Ranging Study

4:00PM-6:00PM: Abstract Number: L20

Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee

4:00PM-6:00PM: Abstract Number: L16

Intra-Articular TPX-100 in Knee Osteoarthritis: Robust Functional Response at 6 and 12 Months Is Associated with Increased Tibiofemoral Cartilage Thickness

4:00PM-6:00PM: Abstract Number: L15

The Diagnostic Accuracy of PET/CT Scan of the Head, Neck and Thorax Compared with Temporal Artery Biopsy in Patients Newly Suspected of Having GCA

4:00PM-6:00PM: Abstract Number: L19

Transcutaneous Electrical Nerve Stimulation (TENS) Reduces Pain and Fatigue and Improves Disease Impact in Women with Fibromyalgia: A Randomized Controlled Trial

« View all sessions from this meeting